Ilaria Gandoglia

8PUBLICATIONS
20CO-AUTHORS
Nanotoxicology, health and safetyInorganic green chemistryArtificial life and complex adaptive systemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Preventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2026
Drug-Induced Amyloid-Related Imaging Abnormalities: A Neurovascular Perspective on Risk Assessment.

|Jan 28, 2026
The Inflammatory Side of Iatrogenic Cerebral Amyloid Angiopathy: Rethinking Therapeutic Opportunities.

Mattia Losa, Andrea Donniaquio, Ilaria Gandoglia

|Jan 28, 2026
Spontaneous and Drug-Induced Amyloid-Related Imaging Abnormalities: Overlaps, Divergences, and Clinical Implications Across a Continuum Between Alzheimer's Disease and Cerebral Amyloid Angiopathy.

Marialuisa Zedde, Mattia Losa, Elena Grisafi

|May 08, 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?

Irene Schiavetti, Matilde Inglese, Jessica Frau

|Oct 03, 2022
The PRESTO study: awareness of stroke symptoms and time from onset to intervention.

Ilaria Gandoglia, Erika Schirinzi, Mehrnaz Hamedani

|Mar 17, 2021
Response to: "MuSK-positive myasthenia may be triggered not only by SARS-CoV-2".

Andrea Assini, Ilaria Gandoglia, Valentina Damato

Pageof 2

Frequent Collaborators

3 joint publications

Mattia Losa

3 joint publications

Fabrizio Piazza

2 joint publications

Andrea Donniaquio

2 joint publications

Marialuisa Zedde